What You Should Know:
– Panacea, the genetic health services provider, announces nationwide commercial availability, enabling consumers to access potentially life-saving testing without doctor visits or insurance approval.
– Offering whole exome sequencing, Panacea conducts in-depth analysis of…
Continue Reading
Osara Health, a provider of evidence-based behavior change intervention for cancer care, is partnering with Allstate Benefits to allow members access to behavior change programs. The company offers members a behavior-change program enabling people living…
Continue Reading
What You Should Know: – Memora Health, a provider of intelligent care enablement platforms, and Intermountain Health, an integrated healthcare delivery system, today announced a multi-year partnership to implement innovative care delivery programs. –…
Continue Reading
By Shania Kennedy
March 05, 2024 – A research team from UC Davis Health developed a machine learning (ML) tool to identify which patients are at increased risk of developing hepatocellular carcinoma (HCC), a common type…
Continue Reading
What You Should Know:
Osara Health, the leading provider of evidence-based behavior change intervention for cancer, announced its partnership with Allstate Benefits, a leading health and supplemental insurer.The first-of-its-kind agreement for the US health insurance market affords…
Continue Reading
Varian, a Siemens Healthineers company, has obtained FDA clearance for its TrueBeam and Edge radiotherapy systems featuring the innovative HyperSight imaging solution. This advancement aims to enhance treatment accuracy and minimize damage to healthy…
Continue Reading
What You Should Know:
– Project Ronin, a software startup focused on applying AI to improve cancer care, announced its closure, Bloomberg first reports.
– The company, co-founded by Oracle co-founder and chairman Larry Ellison, cited…
Continue Reading
What You Should Know:
ArteraAI, a leader in artificial intelligence (AI)-powered cancer tests, today announced a significant achievement – the inclusion of their ArteraAI Prostate Test in the NCCN Clinical Practice Guidelines in Oncology (NCCN…
Continue Reading
At the European Congress of Radiology (ECR) 2024, Hologic, a leading force in women’s health, unveils groundbreaking AI research. Dr. Sarah M. Friedewald presents studies showcasing the prowess of Hologic’s Genius AI® Detection solution…
Continue Reading
What You Should Know:
Belong.Life, a leading global provider of AI-powered patient education and support solutions, has unveiled the BelongAI Dave – Cancer Mentor app to bring the most advanced and comprehensive cancer support technology to…
Continue Reading
